Results 11 to 20 of about 50,884 (170)

Delayed Hypersensitivity with Ferric Carboxymaltose [PDF]

Journal of Clinical and Diagnostic Research, 2017
Ferric Carboxymaltose (FCM) is widely used in the treatment of anaemia of Chronic Kidney Disease (CKD). The clinicians must be alert of the rare adverse events such as hypersensitivity with subsequent doses of FCM. Here, we report a case of a 59-year-old
Surabhi Sridhara, Rajesh Vilakkathala, Ravindra Prabhu, Karan Saraf   +3 more
doaj   +2 more sources

Intravenous ferric carboxymaltose and exercise capacity in iron-deficient kidney transplant recipients: a randomised, placebo-controlled trial in the Netherlands [PDF]

EClinicalMedicine
Summary: Background: Whether correction of iron deficiency improves functional outcomes after kidney transplantation is unknown. We evaluated intravenous ferric carboxymaltose for improving exercise capacity in iron-deficient kidney transplant recipients.
Joanna Sophia J. Vinke, Michele F. Eisenga, Amarens van der Vaart, Caspar J. van Lieshout, Helma W.G.M. Dolmans, Peter van der Meer, Jozine M. ter Maaten, Jacoba M. Spikman, Aaltje L. Ziengs, Jenny E. Kootstra-Ros, Ilja M. Nolte, Carlo G.M. Gaillard, Margriet F.C. de Jong, Stefan P. Berger, Jan-Stephan F. Sanders, Stephan J.L. Bakker, Arjan D. van Zuilen, Martin H. de Borst   +17 more
doaj   +2 more sources

Comparing Ferric Carboxymaltose Versus Iron Sucrose in Patients with Heart Failure [PDF]

Clinical Cardiology, Volume 49, Issue 7, July 2026.
Limited evidence is available to guide the optimal IV iron product in patients with heart failure and iron deficiency. Ferric carboxymaltose use was associated with a higher iron repletion rate than iron sucrose in patients with HF with reduced or mildly reduced ejection fraction and iron deficiency.
Kazuhiko Kido
wiley   +2 more sources

Intravenous ferric carboxymaltose is associated with lowering of plasma phosphate levels in patients with gastric bypass surgery: a retrospective case series

Swiss Medical Weekly
AIMS: Bariatric surgery induces several micronutrient deficiencies that require supplementation. For iron, parenteral infusions are usually preferred over oral supplementation.
Cindy Pereira Portela, Lucie Favre, Isabella Locatelli, Olivier Bonny   +3 more
doaj   +2 more sources

Symptomatic Ferric Carboxymaltose‐Induced Hypophosphataemia: A Case Series of 11 Patients [PDF]

EJHaem
eJHaem, Volume 7, Issue 4, August 2026.
Marina Weerheim, Heva Korevaar, Maurice Bizino, Gijs Fortrie, Loes Vrolijk, Ted Koster, Faiz Karim   +6 more
wiley   +2 more sources

Retrospective Case Reports of Anemic Pregnant Women Receiving Intravenous Ferric Carboxymaltose: Experience from a Tertiary Hospital in Spain [PDF]

Obstetrics and Gynecology International, 2016
Iron deficiency and iron deficiency anemia during pregnancy call for safe treatment options that raise maternal hemoglobin levels and counterbalance iron demand and blood volume expansion while minimizing risks for the growing fetus.
Rafael Aporta Rodriguez, Mariola García Montero, Jose Pablo Lorente Aporta, Carolina Gallego Luque, Alfonso Chacón Mayor, Jose Aragón Ruiz, Virginia Torres Degayón, Claudia García Jimenez, Guadalupe Sanchez Sanchez   +8 more
doaj   +2 more sources

Acute hypersensitivity reaction following intravenous ferric carboxymaltose injection for iron deficiency anaemia: a case report. [PDF]

Critical Care Innovations, 2023
Ferric carboxymaltose (FCM) is a non-dextran iron preparation used for intravenous treatment of iron deficiency anaemia (IDA) in adult patients with intolerance or poor response to oral iron therapy.
Neeraj Kumar, Preeti Bala Gautam, Sarfaraz Ahmad, Danish Qutub, Indira Prasad   +4 more
doaj   +2 more sources

Efficacy of ferric carboxymaltose versus iron sucrose in non-dialysis dependent chronic kidney disease

Journal of the Pakistan Medical Association
Objective: To determine the efficacy of ferric carboxymaltose versus iron sucrose in non-dialysis-dependent chronic kidney disease patients. Method: The randomised controlled trial was conducted at the Nephrology Outpatient Department of the Sindh ...
Kamlesh Kumar, Sarfaraz Sarwar, Rabeea Abbas, Nida Vallani, Nazarul Hassan Jaffry, Zara Khan   +5 more
doaj   +2 more sources

Case Report: High-Dose Ferric Carboxymaltose as an Antianaemic Agent to Avoid Haemotransfusions after Total Hip Replacement

Medicina
This article highlights a case of high-dose ferric carboxymaltose (Ferinject®) for the treatment of perioperative iron deficiency anaemia in a 39-year-old patient with dysplastic coxarthrosis.
Maiya Konkayeva, Assiya Kadralinova, Nazerke Zhanarystan, Nurlan Akhatov, Aidos Konkayev   +4 more
doaj   +2 more sources

Efficacy and safety of single high-dose intravenous ferric carboxymaltose in patients undergoing hemodialysis: a multicenter, single-arm, open-label, clinical trial [PDF]

BMC Nephrology
Background Iron-deficiency anemia is common in patients undergoing hemodialysis, and intravenous iron therapy is often preferred because oral iron is poorly tolerated and less effective. Ferric caboxymaltose, a high-dose intravenous iron formulation, has
Kosuke Osawa, Shin-ichi Araki, Yusuke Tanaka, Masaki Ohya, Toshihiro Kodama, Yasushi Saika, Shigeo Negi, Shuto Yamamoto, Tsunehisa Matsuo, Yoji Ogawa, Norifumi Katayama, Yusuke Shigi, Tomomi Naito, Toshio Shimokawa, Takashi Shigematsu   +14 more
doaj   +2 more sources